{"vid":"V819","name":"p23_2","file_id":"F1","var_dcml":"0","var_intrvl":"discrete","var_width":"8","var_respunit":"The post abortion care healthcare provider to the woman receiving treatment for abortion complications, the type of treatment received for complications, and the delays in access to post-abortion care","var_qstn_preqtxt":"N\/A","var_qstn_qstnlit":"What route was the oxytocin administered_IV","var_qstn_postqtxt":"N\/A","var_qstn_ivulnstr":"N\/A","var_val_range":[{"units":null,"min":"0","max":"1"}],"var_universe":"Healthcare provider","universe_clusion":"I","var_sumstat":[{"value":"1614","type":"vald"},{"value":"2531","type":"invd"}],"var_txt":"The  route on how the oxytocin was administered_IV","var_catgry":[{"value":"0","labl":null,"stats":"741","type":"freq"},{"value":"1","labl":null,"stats":"873","type":"freq"},{"value":"Sysmiss","labl":null,"stats":"2531","type":"freq"}],"var_format":"numeric","var_format_schema":"other","fid":"F1","sid":"188","survey_idno":"DDI-KEN-APHRC-KAS-PMS-2022-v1.0"}